吡嗪酰胺诱发的高尿酸血症。
Pyrazinamide-induced hyperuricemia.
作者信息
Pham Antony Q, Doan Anh, Andersen Matt
出版信息
P T. 2014 Oct;39(10):695-715.
Abstract
Elevated uric acid levels can cause crystal deposition and may lead to gout, urolithiasis, and urate nephropathy. The authors report on the case of a 34-year-old male whose hyperuricemia was associated with the antituberculous drug pyrazinamide.
摘要
尿酸水平升高会导致晶体沉积，并可能引发痛风、尿路结石和尿酸盐肾病。作者报告了一例34岁男性病例，其高尿酸血症与抗结核药物吡嗪酰胺有关。
相似文献
1
Pyrazinamide-induced hyperuricemia.
P T. 2014 Oct;39(10):695-715.
2
Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide.
Kekkaku. 2008 Jul;83(7):497-501.
3
Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study.
Arthritis Rheumatol. 2018 Nov;70(11):1847-1852. doi: 10.1002/art.40572. Epub 2018 Aug 27.
4
[Historical review of gout and hyperuricemia investigations].
Nihon Rinsho. 2008 Apr;66(4):624-35.
5
Hereditary nephropathy associated with hyperuricemia and gout.
Arch Intern Med. 1993 Feb 8;153(3):357-65.
6
Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 2: clinical features, diagnosis and differential diagnostics.
Z Gerontol Geriatr. 2018 Jul;51(5):579-584. doi: 10.1007/s00391-017-1198-2. Epub 2017 Feb 23.
7
[Hyperuricemia and Gout].
G Ital Nefrol. 2016;33(S68).
8
[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Nihon Rinsho. 2008 Apr;66(4):729-35.
9
Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
Rheum Dis Clin North Am. 1988 Aug;14(2):377-94.
10
Clinical manifestations of hyperuricemia and gout.
Cleve Clin J Med. 2008 Jul;75 Suppl 5:S5-8. doi: 10.3949/ccjm.75.suppl_5.s5.
引用本文的文献
1
Risk of Gout Among Patients With Tuberculosis: A Nationwide Cohort Study in South Korea.
Int J Rheum Dis. 2025 Mar;28(3):e70197. doi: 10.1111/1756-185X.70197.
2
Treatment and Toxicity Considerations in Tuberculosis: A Narrative Review.
Cureus. 2024 Jun 19;16(6):e62698. doi: 10.7759/cureus.62698. eCollection 2024 Jun.
3
Metabolic Rewiring of upon Drug Treatment and Antibiotics Resistance.
Metabolites. 2024 Jan 18;14(1):63. doi: 10.3390/metabo14010063.
4
The Stiff Joint: Comparative Evaluation of Monotherapy and Combination Therapy With Urate Lowering Agents in Managing Acute Gout.
Cureus. 2023 Sep 12;15(9):e45087. doi: 10.7759/cureus.45087. eCollection 2023 Sep.
5
Adverse drug reactions and associated factors in multidrug-resistant tuberculosis: A retrospective review of patient medical records at Mbarara Regional Referral Hospital, Uganda.
SAGE Open Med. 2023 May 3;11:20503121231171350. doi: 10.1177/20503121231171350. eCollection 2023.
6
Environmental Triggers of Hyperuricemia and Gout.
Rheum Dis Clin North Am. 2022 Nov;48(4):891-906. doi: 10.1016/j.rdc.2022.06.009.
7
ANCA associated glomerulonephritis in tuberculosis: a paradoxical reaction.
BMJ Case Rep. 2021 Jun 15;14(6):e241904. doi: 10.1136/bcr-2021-241904.
8
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout.
Drugs Context. 2019 May 29;8:212581. doi: 10.7573/dic.212581. eCollection 2019.
9
Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study.
Lung India. 2017 Nov-Dec;34(6):522-526. doi: 10.4103/0970-2113.217569.
10
Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study.
Medicine (Baltimore). 2017 Jul;96(28):e7482. doi: 10.1097/MD.0000000000007482.
本文引用的文献
1
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.
BMC Nephrol. 2013 Jul 29;14:164. doi: 10.1186/1471-2369-14-164.
2
Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia.
Singapore Med J. 2013 Jun;54(6):e125-6. doi: 10.11622/smedj.2013097.
3
Therapeutic perspectives on uricases for gout.
Joint Bone Spine. 2012 May;79(3):237-42. doi: 10.1016/j.jbspin.2012.01.004. Epub 2012 Feb 25.
4
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
J Rheumatol. 2007 Oct;34(10):2093-8. Epub 2007 Sep 15.
5
Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Pediatr Transplant. 2006 Sep;10(6):665-8. doi: 10.1111/j.1399-3046.2006.00556.x.
6
Gout and hyperuricemia.
Am Fam Physician. 1999 Feb 15;59(4):925-34.
7
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
8
Hyperuricemia due to ethambutol.
N Engl J Med. 1972 Apr 6;286(14):761-2. doi: 10.1056/NEJM197204062861407.
9
Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid).
Am J Med. 1969 Oct;47(4):575-92. doi: 10.1016/0002-9343(69)90188-0.
10
Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.
Am J Med. 1987 Mar;82(3):421-6. doi: 10.1016/0002-9343(87)90441-4.
Zotero 插件